Skip to main content
OpenTrials
Completed

NCT Number: NCT02455921

Neuromuscular Blockade Reversal Agent Effect on Postoperative Cognitive Function and Behaviour in Children

The aim of this prospective randomized study is to investigate comparatively the effect of neostigmine-atropine versus sugammadex on speed and quality of recovery and on postoperative cognitive function & behavior in children undergoing ENT surgery under general anaesthesia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 year–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

2nd Department of Anesthesiology, Attikon University Hospital

Athens, Attica, 12462, Greece

About this study

The aim of this prospective randomized study is to investigate comparatively the effect of neostigmine-atropine vs sugammadex on time of achieving extubation, quality of recovery, postoperative cognitive function and behaviour of children undergoing ENT surgery under general anaesthesia.

In this study after parental approval has been obtained, children with age 6-12 yrs undergoing tonsillectomy and/or adenoidectomy under general anaesthesia will be included. General anaesthesia will be performed using Total Intravenous Anaesthesia (TIVA) technique with continuous infusion of propofol and remifentanil. Rocuronium will be used to achieve neuromuscular blockade (NMB). Neuromuscular reversal will be performed using either atropine-neostigmine or sugammadex. Patients will be divided into 2 groups according to the type of NMB reversal agent used. Intraoperative monitoring will include Bispectral Index Sedation (BIS), SpO2, capnography, noninvasive measurements of blood pressure, heart rate and train of four (TOF).

Children will be assessed preoperatively (one day before surgery and at the morning of day of surgery), intraoperatively, immediate postoperatively and will be followed up for 15 postoperative days. Additionally, parents will be cooperated and questioned.

The primary end-points of the study include the comparative investigation of the effect of neostigmine-atropine vs sugammadex on time of achieving extubation, quality of recovery, and postoperative cognitive function of children. Secondary endpoints will include side effects, signs of residual neuromuscular blockade, agitation and postoperative behavioural changes of children.

For this purpose the following scales and questionnaires will be used:

  • Emotionality, Activity, Sociability & Impulsivity (EASI) Scale
  • The Modified Mini-Mental State (3MS) Test - Version G Greek
  • Yale Preoperative Anxiety Scale
  • Aldrete score
  • Emergence Delirium (PAED) scale
  • Wong-Baker scale
  • Visual Analogue Scale (VAS) (0-10)
  • Child Post- Hospital Behavior Questionnaire (PHBQ)]
  • Post discharge repeated questionnaire

All the questionnaires will be translated, culturally adapted and validated in Greek. Analysis of the data will include pair wise T test in order to find statistical differences between the two techniques and regression analysis models in order to revile significant correlations between dependent and independent variables. Statistical analysis will be performed with the use of SPSS21 for Windows.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children undergoing ENT surgery under general anaesthesia.

Exclusion criteria

  • Parents refusal
  • Cognitive impairment
  • Difficulty in communication due to language issues
  • Psychiatric disorder
  • Severe systematic disorder
  • Known allergy to any drug used

Treatment and study plan

neostigmine - atropine

Drug

Efficacy, safety and effect on cognitive and behavioural function

Sugammadex

Drug

Efficacy, safety and effect on cognitive and behavioural function

Other names: Bridion

Primary outcomes

  1. time of achieving extubation

    Time frame: 10 min

    time of achieving extubation

Secondary outcomes

  1. signs of residual neuromuscular blockade

    Time frame: 1 hour

    number of participants with signs of residual

  2. Behavioural function

    Time frame: up to 15th postoperative day

    changes using Battery test

Sponsors and collaborators

Lead sponsor

Attikon Hospital

Other

Registry information

Official study title

Comparative Effect of Neuromuscular Blockade Reversal Agent on Extubation Conditions, Postoperative Cognitive Function and Behaviour of School-aged Children Undergoing Ear Note Throat (ENT) Surgery

Important dates

Study start
2015
Primary completion
2018
Study completion
2018
First posted
May 28, 2015
Registry last updated
Oct 24, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.